Abbott falls as it cuts 2026 sales growth view, plans to spin off nutrition business
ABT•Abbott lowered its 2026 sales growth forecast to about 6% from 6.5% to 7.5% and plans to separate its nutrition business into an independent, publicly traded company by the end of 2027.
1. Forecast and planned separation
Abbott now expects 2026 sales growth of about 6%, down from its prior forecast of 6.5% to 7.5%. The company plans to separate its nutrition business into an independent, publicly traded company, with completion expected by the end of 2027. Abbott shares fell 3.88% to $98.47 in premarket trading.
